Universe Pharmaceuticals (UPC) Retained Earnings: 2020-2024
Historic Retained Earnings for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to -$10.2 million.
- Universe Pharmaceuticals' Retained Earnings fell 328.77% to -$10.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$10.2 million, marking a year-over-year decrease of 328.77%. This contributed to the annual value of -$10.2 million for FY2024, which is 328.77% down from last year.
- Latest data reveals that Universe Pharmaceuticals reported Retained Earnings of -$10.2 million as of FY2024, which was down 328.77% from -$2.4 million recorded in FY2023.
- In the past 5 years, Universe Pharmaceuticals' Retained Earnings ranged from a high of $13,739.0 billion in FY2020 and a low of -$10.2 million during FY2024.
- Its 3-year average for Retained Earnings is $1.3 million, with a median of -$2.4 million in 2023.
- As far as peak fluctuations go, Universe Pharmaceuticals' Retained Earnings soared by 34.86% in 2022, and later plummeted by 328.77% in 2024.
- Universe Pharmaceuticals' Retained Earnings (MRY) stood at $13,739.0 billion in 2020, then tumbled by 100.00% to $25.1 million in 2021, then tumbled by 34.86% to $16.3 million in 2022, then plummeted by 114.53% to -$2.4 million in 2023, then crashed by 328.77% to -$10.2 million in 2024.
- Its Retained Earnings was -$10.2 million in FY2024, compared to -$2.4 million in FY2023 and $16.3 million in FY2022.